Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cellular Therapy for In Utero Repair of Myelomeningocele - The CuRe Trial — Stella

Home/Myelomeningocele/

View on ClinicalTrials.gov

Recruiting

Back to Myelomeningocele trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

UC Davis Health, Sacramento, California

Key details

Phase

Early testing / Safety & dosing

Sponsor

University of California, Davis

Collaborators

California Institute for Regenerative Medicine (CIRM)

Enrollment target

~55 participants

Started

June 2021

Primary completion

March 2027

Age range

19 Weeks – 25 Weeks

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.